Dr Prasad currently serves as the Director of the Center for Biologics Evaluation and Resesarch (CBER) at the US FDA. The audio on this platform were posted before my FDA employment and do not necessarily represent the views of the FDA or the United States. This site will be inactive during my federal service.
A podcast on medicine, oncology, & health policy.
Host: Vinay Prasad, MD MPH from University of California San Francisco.
Tweet your feedback to @Plenary_Session or e-mail plenarysessionpodcast@gmail.com
| Title
|
Date published
|
|
|
|
1.36 Generic Price Competition & Military Surgical Advances with Dr. Martin Schreiber
|
2019-01-15
|
|
|
|
1.35 BONUS! Conflict of Interest in Oncology
|
2019-01-10
|
|
|
|
1.34 Endpoints in ECOG-ACRIN 2511, Update to KEYNOTE-024, & Mentorship with Dr. Joseph Shatzel
|
2019-01-10
|
|
|
|
1.33 Guarantee-Time Bias & Trials, Philanthropy, and Cancer Research with Dr. Tom Beer
|
2019-01-05
|
|
|
|
1.32.1 Radiation Oncology with Dr. Brian Kavanagh
|
2019-01-04
|
|
|
|
1.32 Rating Metrics, Conflict of Interest in the News, & Radiation Oncology with Dr. Brian Kavanagh
|
2019-01-03
|
|
|
|
1.31 Ketogenic Diet, COMET-1 and COMET-2, the Health Insurance Marketplace with Dr. Jane Zhu
|
2018-12-27
|
|
|
|
1.30 BONUS! Clinical Trial Endpoints, Drug Approval, Incentives in Oncology
|
2018-12-19
|
|
|
|
1.29 RCT of Parachutes and Frameworks for Internal Medicine with Dr. Andre Mansoor
|
2018-12-18
|
|
|
|
1.28 Questionable FDA Drug Approvals and Building a Career with Dr. Chadi Nabhan
|
2018-12-13
|
|
|
|
1.27 BONUS! Medical Reversal
|
2018-12-06
|
|
|
|
1.26 Lesson From an ASH Abstract, Behind the Scenes of a Residency Program with Dr. Sima Desai
|
2018-12-04
|
|
|
|
1.25 Welch's Legacy, Interpreting NGS, Uncertainty over Pregabalin, Beyond EBM with Dr. Sam Edwards
|
2018-11-27
|
|
|
|
1.24 Useless Medical Conferences and Dr. Adam Obley on Vascepa, Fish Oil, Vitamin D and Methotrexate
|
2018-11-20
|
|
|
|
1.23 BONUS! Developing Technology with Fewer Reversals: Maybe We Need More Translation Failure
|
2018-11-15
|
|
|
|
1.22 Elo-Pom-Dex, Immunotherapy Combos, Inherent Bias, and the FDA with Dr. Erick Turner
|
2018-11-13
|
|
|
|
1.21 Nab-Paclitaxel in CCA, OS of PALOMA-3, Transparency, and Dr. Talal Hilal's Advice for Trainees
|
2018-11-06
|
|
|
|
1.20 Precision Oncology: Some Benefit, Mostly Hype and Mentorship with Dr. Andrae Vandross
|
2018-10-30
|
|
|
|
1.19 BONUS! Introduction to Cancer Drug Policy
|
2018-10-26
|
|
|
|
1.18 IMpassion130 and Hot-Spotting with Dr. Brian Chan
|
2018-10-23
|
|
|
